Produção Nacional
Revisado por pares
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
2018; Elsevier BV; Volume: 18; Issue: 9 Linguagem: Inglês
10.1016/s1473-3099(18)30348-7
ISSN1474-4457
AutoresRobert J. Commons, J. A. Simpson, Kamala Thriemer, Georgina Humphreys, Tesfay Abreha, Sisay Getachew Alemu, Arletta Añez, Nicholas M. Anstey, Ghulam Rahim Awab, J. Kevin Baird, Bridget E. Barber, Isabelle Borghini-Fuhrer, Cindy S. Chu, Umberto D’Alessandro, Prabin Dahal, André Daher, Peter J. de Vries, Annette Erhart, Margarete S. Gomes, Lilia González-Cerón, Matthew J. Grigg, Aliehsan Heidari, Jimee Hwang, Piet A. Kager, Tsige Ketema, Wasif Ali Khan, Marcus Lacerda, Toby Leslie, Benedikt Ley, Kartini Lidia, Wuelton Marcelo Monteiro, François Nosten, Dhélio B. Pereira, Giao T. Phan, Aung Pyae Phyo, Mark Rowland, Kavitha Saravu, Carol Hopkins Sibley, André M. Siqueira, Kasia Stepniewska, Inge Sutanto, Walter Taylor, Guy Thwaites, Trần Quang Bình, Hien Tran, Neena Valecha, José Luiz Fernandes Vieira, Sonam Wangchuk, Timothy William, Charles J. Woodrow, Lina Zuluaga-Idárraga, Philippe J. Guérin, Nicholas J. White, Ric N. Price,
Tópico(s)Mosquito-borne diseases and control
ResumoChloroquine remains the mainstay of treatment for Plasmodium vivax malaria despite increasing reports of treatment failure. We did a systematic review and meta-analysis to investigate the effect of chloroquine dose and the addition of primaquine on the risk of recurrent vivax malaria across different settings.
Referência(s)